DE68909451T2 - Peptide mit inhibitorischer Wirkung auf enzymatische Systeme, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. - Google Patents

Peptide mit inhibitorischer Wirkung auf enzymatische Systeme, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.

Info

Publication number
DE68909451T2
DE68909451T2 DE89104007T DE68909451T DE68909451T2 DE 68909451 T2 DE68909451 T2 DE 68909451T2 DE 89104007 T DE89104007 T DE 89104007T DE 68909451 T DE68909451 T DE 68909451T DE 68909451 T2 DE68909451 T2 DE 68909451T2
Authority
DE
Germany
Prior art keywords
processes
preparation
pharmaceutical compositions
compositions containing
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89104007T
Other languages
English (en)
Other versions
DE68909451D1 (de
Inventor
Dario Chiarino
Angelo Carenzi
Bella Davide Della
Franco Pellacini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Publication of DE68909451D1 publication Critical patent/DE68909451D1/de
Application granted granted Critical
Publication of DE68909451T2 publication Critical patent/DE68909451T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/32—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to an acyclic carbon atom of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE89104007T 1988-03-16 1989-03-07 Peptide mit inhibitorischer Wirkung auf enzymatische Systeme, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen. Expired - Fee Related DE68909451T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8819790A IT1216103B (it) 1988-03-16 1988-03-16 Peptidi ad attivita' farmaceutica.

Publications (2)

Publication Number Publication Date
DE68909451D1 DE68909451D1 (de) 1993-11-04
DE68909451T2 true DE68909451T2 (de) 1994-02-10

Family

ID=11161236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89104007T Expired - Fee Related DE68909451T2 (de) 1988-03-16 1989-03-07 Peptide mit inhibitorischer Wirkung auf enzymatische Systeme, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.

Country Status (12)

Country Link
US (1) US5028626A (de)
EP (1) EP0332999B1 (de)
JP (1) JPH024767A (de)
AT (1) ATE95169T1 (de)
AU (1) AU611269B2 (de)
CA (1) CA1325695C (de)
DE (1) DE68909451T2 (de)
ES (1) ES2059594T3 (de)
IE (1) IE890747L (de)
IL (1) IL89537A (de)
IT (1) IT1216103B (de)
ZA (1) ZA891784B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1216104B (it) * 1988-03-16 1990-02-22 Zambon Spa Peptidi ad attivita' farmaceutica.
ES2052454B1 (es) * 1992-12-31 1995-01-16 Zambon S A Dipeptidos y composiciones que los contienen con accion farmaceutica contra el envejecimiento.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2393788A2 (fr) * 1977-06-10 1979-01-05 Microbial Chem Res Found Derives de bestatine
JPS6026099B2 (ja) * 1977-09-21 1985-06-21 財団法人微生物化学研究会 ペプチド、その酸附加塩およびその製造法
JPS58121259A (ja) * 1982-01-09 1983-07-19 Microbial Chem Res Found ベスタチン新規誘導体
US4883808A (en) * 1987-08-27 1989-11-28 American Biotechnology Company Condensation products of cyclic diketones and ascorbic acid as immunomodulatory agents

Also Published As

Publication number Publication date
JPH024767A (ja) 1990-01-09
US5028626A (en) 1991-07-02
IL89537A (en) 1993-06-10
ZA891784B (en) 1989-11-29
IE890747L (en) 1989-09-16
AU3138489A (en) 1989-09-21
EP0332999A2 (de) 1989-09-20
CA1325695C (en) 1993-12-28
EP0332999A3 (en) 1990-11-28
DE68909451D1 (de) 1993-11-04
EP0332999B1 (de) 1993-09-29
AU611269B2 (en) 1991-06-06
IT8819790A0 (it) 1988-03-16
ES2059594T3 (es) 1994-11-16
ATE95169T1 (de) 1993-10-15
IL89537A0 (en) 1989-09-10
IT1216103B (it) 1990-02-22

Similar Documents

Publication Publication Date Title
ATE98651T1 (de) Peptide mit tachykininantagonistischer aktivitaet, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
IE811680L (en) Tri-substituted imidazole derivatives
ATE104279T1 (de) 4-fluorbenzolderivate, herstellungsverfahren und diese enthaltende pharmazeutische zusammensetzungen.
NO900306D0 (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
DE69130412T2 (de) Pyrazolopyridinverbindung und Verfahren zu ihrer Herstellung
IT1224405B (it) Composti attivi sul sistema cardiovascolare
ATE89549T1 (de) Peptide mit inhibitorischer wirkung auf enzymatische systeme, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EA199901012A1 (ru) Фармацевтические композиции на основе тизоксанида и нитазоксанида
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
DE68909451T2 (de) Peptide mit inhibitorischer Wirkung auf enzymatische Systeme, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
DE69402004T2 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EA199700302A1 (ru) Биологически активные уреидо-производные, полезные при лечении рассеянного склероза
IT1224404B (it) Composti attivi sul sistema cardiovascolare
DK0578535T3 (da) Hidtil ukendt peptid-derivater, der er aktive i celleadhæsionsprocesser, fremgangsmåde til deres fremstilling samt farmaceutiske sammensætninger indeholdende derivarerne
TH14322EX (th) สารประกอบไทรไซคลิคที่ต่อต้านฤทธิ์ของแทคิควินีน, การเตรียมและสูตรผสมทางเภสัชกรรมที่ประกอบด้วย สารประกอบนั้น

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee